Arnold D. Essenburg - Concepedia

Concepedia

Author

Arnold D. Essenburg

Warde Medical Laboratory

Also Known As

A D Essenburg, A Essenburg, A. D. ESSENBURG, A. D. Essenburg, A. Essenburg, A.D. Essenburg, Arnold D. Essenburg, Arnold Essenburg

49

Publications

1.8K

Citations

21

H-Index

45

Concepts

All Affiliations

Warde Medical Laboratory Pfizer (United States)Rockefeller University Columbia University

AD

About

Arnold D. Essenburg is an author at Warde Medical Laboratory specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.1K
2	Biochemistry	12	12	514
3	Natural Sciences	8	8	265
4	Health Sciences	3	3	441
5	Public Health	1	1	77

Arnold D. Essenburg

×

27

Publications

1.8K

Citations

21

H-Index

	Year	Citations
Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 Levels Yu‐Min Kuo, Mark R. Emmerling, Charles L. Bisgaier, Biochemical and Biophysical Research Communications Neurodegenerative DiseasesAlzheimer's DiseaseLow-density LipoproteinBrain Aβ 1–42Vascular Dementia	1998	309
Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. Peter Weinstock, C L Bisgaier, Katriina Aalto‐Setälä, Journal of Clinical Investigation Lipoprotein LipaseCell DeathHyperlipidemiaInflammationMetabolic Syndrome	1995	303
In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT. BR Krause, Mitchell J. Anderson, C L Bisgaier, Journal of Lipid Research	1993	148
Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action. Sabine Haubenwallner, Arnold D. Essenburg, B.C. Barnett, Journal of Lipid Research	1995	120
Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice Peter Weinstock, C L Bisgaier, Tony Hayek, Journal of Lipid Research NutritionFood IntakeHyperlipidemiaOxidative StressMetabolic Syndrome	1997	120
Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. Katriina Aalto‐Setälä, C L Bisgaier, Anthony M.‐H. Ho, Journal of Clinical Investigation Lipid AnalysisNutritionGastroenterologyPathologyDietary Lipid Absorption	1994	77
Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors C L Bisgaier, Arnold D. Essenburg, Bruce J. Auerbach, Journal of Lipid Research	1997	72
Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agents Bruce D. Roth, C. John Blankley, M. L. HOEFLE, Journal of Medicinal Chemistry Chemical BiologyPharmaceutical ChemistryMedicinal ChemistryFatty Acid AnilidesPharmacological Study	1992	67
A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor Charles L. Bisgaier, Arnold D. Essenburg, B.C. Barnett, Journal of Lipid Research	1998	59
Inhibitors of acyl-CoA:cholesterol acyltransferase. 4. A novel series of urea ACAT inhibitors as potential hypocholesterolemic agents Bharat K. Trivedi, Ann Holmes, Terri L. Stoeber, Journal of Medicinal Chemistry	1993	54

Page 1